The beige mutation in the mouse selectively impairs natural killer cell function.

作者信息

Roder J, Duwe A

出版信息

Nature. 1979 Mar 29;278(5703):451-3. doi: 10.1038/278451a0.

DOI:10.1038/278451a0

PMID:313007

Abstract

摘要

相似文献

The beige mutation in the mouse selectively impairs natural killer cell function.

Nature. 1979 Mar 29;278(5703):451-3. doi: 10.1038/278451a0.

The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect.

J Immunol. 1979 Nov;123(5):2174-81.

Experimental histoplasmosis in the beige mouse.

J Leukoc Biol. 1987 Mar;41(3):228-35. doi: 10.1002/jlb.41.3.228.

Clearance of Giardia muris infection in mice deficient in natural killer cells.

Infect Immun. 1986 Dec;54(3):903-4. doi: 10.1128/iai.54.3.903-904.1986.

Normal levels of natural cytotoxic cells against solid tumours in NK-deficient beige mice.

Nature. 1981 Mar 19;290(5803):254-7. doi: 10.1038/290254a0.

Adaptive immune defects and delayed rejection of allogeneic tumor cells in beige mice.

Cell Immunol. 1984 Sep;87(2):348-56. doi: 10.1016/0008-8749(84)90004-2.

Defective T-cell response in beige mutant mice.

Nature. 1982 Jan 21;295(5846):240-1. doi: 10.1038/295240a0.

The C57BL/6 nude, beige mouse: a model of combined T cell and NK effector cell immunodeficiency.

Cell Immunol. 1989 Apr 15;120(1):218-29. doi: 10.1016/0008-8749(89)90189-5.

Effects of the beige mutation and irradiation on natural resistance to marrow grafts.

J Immunol. 1983 Jan;130(1):484-9.

The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function.

J Immunol. 1979 Nov;123(5):2168-73.

引用本文的文献

Murine Models of Familial Cytokine Storm Syndromes.

Adv Exp Med Biol. 2024;1448:481-496. doi: 10.1007/978-3-031-59815-9_33.

Animal model considerations for chordoma research: reproducing the tumor microenvironment with humanized mice.

Front Oncol. 2024 Mar 13;14:1330254. doi: 10.3389/fonc.2024.1330254. eCollection 2024.

Xenograft and organoid models in developing precision medicine for gastric cancer (Review).

Int J Oncol. 2024 Apr;64(4). doi: 10.3892/ijo.2024.5629. Epub 2024 Feb 23.

FAP-retargeted Ad5 enables in vivo gene delivery to stromal cells in the tumor microenvironment.

Mol Ther. 2023 Oct 4;31(10):2914-2928. doi: 10.1016/j.ymthe.2023.08.018. Epub 2023 Aug 28.

Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.

Cancer Cell Int. 2023 Jun 21;23(1):120. doi: 10.1186/s12935-023-02953-3.

The lysosomal trafficking regulator is necessary for normal wound healing.

Wound Repair Regen. 2022 Jan;30(1):82-99. doi: 10.1111/wrr.12984. Epub 2021 Nov 27.

Comparison of Genetically Engineered Immunodeficient Animal Models for Nonclinical Testing of Stem Cell Therapies.

Pharmaceutics. 2021 Jan 20;13(2):130. doi: 10.3390/pharmaceutics13020130.

Distinctive phenotypes and functions of innate lymphoid cells in human decidua during early pregnancy.

Nat Commun. 2020 Jan 20;11(1):381. doi: 10.1038/s41467-019-14123-z.

Application of Highly Immunocompromised Mice for the Establishment of Patient-Derived Xenograft (PDX) Models.

Cells. 2019 Aug 13;8(8):889. doi: 10.3390/cells8080889.

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.

Front Immunol. 2018 Nov 5;9:2551. doi: 10.3389/fimmu.2018.02551. eCollection 2018.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验